The finding that low levels of HOMER3 and its downstream target GABPB1 led to mitochondrial dysfunction and decreased proliferation and invasive ability of lung cancer cells raises the possibility that targeting mitochondrial synthesis might be an important and promising therapeutic strategy for NSCLC. Here, HOMER3 is linked to lung cancer.